Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Angiosarcoma].

Toshiaki Saida1

  • 1Dept. of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 30, 2004
PubMed
Summary

Angiosarcoma is a rare cancer of endothelial cells with high metastatic potential. This review explores recent advances in multimodal therapies including surgery, radiation, chemotherapy, and biotherapy for improved patient survival.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The BRAAFF-Annotated Acral Lesions Dataset (BALD): A Curated Set of Dermatoscopic Images of Acral Melanoma and Nevi from Various Sources.

The Journal of investigative dermatology·2025
Same author

Validation of a Dermatoscopy-Based Algorithm for the Diagnosis of Acral Melanoma.

Dermatology (Basel, Switzerland)·2024
Same author

Dermoscopy for Acral Melanocytic Lesions: Revision of the 3-step Algorithm and Refined Definition of the Regular and Irregular Fibrillar Pattern.

Dermatology practical & conceptual·2022
Same author

Stem cell spreading dynamics intrinsically differentiate acral melanomas from nevi.

Cell reports·2021
Same author

ALK-positive atypical Spitz tumour with conspicuous rosette-like structures.

European journal of dermatology : EJD·2021
Same author

[Melanoma and Non‒Melanoma Skin Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2021

Area of Science:

  • Oncology
  • Pathology

Context:

  • Angiosarcoma is a rare, aggressive vascular cancer originating from endothelial cells.
  • Characterized by a high propensity for hematogenous metastasis, leading to a poor prognosis.

Purpose:

  • To review recent advancements in the multimodal management of angiosarcoma.
  • To discuss current and emerging therapeutic strategies.

Summary:

  • Explores surgical interventions, radiation therapy techniques, chemotherapy regimens, and biotherapy options.
  • Highlights the importance of combining these modalities for potential survival benefits.

Impact:

  • Provides an overview of current therapeutic landscape for angiosarcoma.
  • Informs clinical decision-making and future research directions in managing this fatal disease.